BrainCool AB
The answer first
Does BrainCool beat the market?
Yes, BrainCool has beaten the market over the last year.
The ranking · Quality, value and trend combined
Better than 73% of Nordic stocks
- Quality78
- Value9
- Trend99
No. 33 of 195 in healthcare
Max for seven days
Follow BrainCool with AuroraAurora lets you know at the next report. No card.
Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.
Follow your thesis
Ask Aurora about BrainCool
Your first answer is free, no account needed.
Do you own BrainCool, or are you thinking about it?
See it next to the rest of your portfolio, or build your first one with BrainCool and a few more. Free, no card.
Super Stock+44.6%In short
- BrainCool has risen 103.4% over the past year, including dividends.
- Overall, BrainCool ranks better than 73% of Nordic stocks on quality, value and trend.
- The largest fall over the past three years was 92.4%. The price is 92.7% below its peak now.
What do analysts think of BrainCool?
Quality, value and trend
Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.
Quality, value and trend together. Better than 73% of Nordic stocks.
No. 33 of 195 in healthcare
High A solid company: it earns well on its money and has healthy finances.
No. 57 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50
- Debt to equityBorrowings divided by equity0.26
- Asset turnoverSales divided by everything the company owns0.26
- Return on equityProfit divided by equity−20.7%
- Cash conversionOperating cash flow divided by profit–
The ranking is built on equity ratio, ROA and how steadily profit grows.
Low High price: buyers pay a lot today, often because they expect growth.
No. 137 of 197 in healthcareTypical in healthcare: 20Typical in the Nordics: 50
- P/BPrice divided by equity3.0
- P/SPrice divided by sales10.6
- P/EPrice divided by earningsnegative earnings
- P/CFPrice divided by operating cash flownegative earnings
The ranking is built on P/E, P/B and P/S.
High Tailwind in the share price: it has risen more than most over the last year.
No. 3 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50
- 3 months+68.7%
- 6 months+42.9%
- 9 months+136.7%
- 12 months+103.4%
The ranking is built on 3, 6 and 12–1 months.
Return and risk
Return with dividends reinvested.
The funds that own BrainCool
One fund we follow owns BrainCool. The share is how much of the fund the stock makes up.
- Sweden1
From the funds' latest known holdings.
About BrainCool
BrainCool AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 8 employees.
BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers BrainCool system, a system to monitor and control a patient's temperature to anatomical zones for head/neck, thighs, and torso. It also offers RhinoChill system, a portable and battery-powered cooling product to spray liquid coolant for patient's nostrils with a catheter; Cooral system provides medical professionals a way to reduce the risk of oral mucositis; and IQool system, a temperature management system that monitors and controls a patient's temperature.


See the full analysis of BrainCool.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
Free forever · No card